Please use this identifier to cite or link to this item:
http://repo.knmu.edu.ua/handle/123456789/23900
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Zhuravlyova, Larysa | - |
dc.contributor.author | Kulikova, Mariia | - |
dc.date.accessioned | 2019-09-12T07:17:20Z | - |
dc.date.available | 2019-09-12T07:17:20Z | - |
dc.date.issued | 2019 | - |
dc.identifier.citation | Zhuravlyova L. The influance of dapagliflosin on The level of blood pressure in patients with type 2 diabetes mellitus and arterial hypertension / L. Zhuravlyova, M. Kulikova // 29th European Meeting on Hypertension and Cardivascular protection, Milan, Italy, june 21–24, 2019. – Milan, 2019. – P. 157. | ru_RU |
dc.identifier.uri | https://repo.knmu.edu.ua/handle/123456789/23900 | - |
dc.description.abstract | The combination of type 2 diabetes mellitus (DM-2) and arterial hypertension (AH) increases the risk of development of cardiovascular complications in 2-3 times. One of the mechanisms for the development of DM-2 is the increasing of the reabsorption of glucose by the kidneys, that is why we have the introduction into the practice of new class of oral hypoglycemic drugs - sodium-glucose co-transporter 2 inhibitors (SGLT2). | ru_RU |
dc.language.iso | en | ru_RU |
dc.subject | dapagliflozin | ru_RU |
dc.subject | blood pressure | ru_RU |
dc.subject | type 2 diabetes mellitus | ru_RU |
dc.subject | arterial hypertension | ru_RU |
dc.title | The influance of dapagliflosin on the level of blood pressure in patients with type 2 diabetes mellitus and arterial hypertension | ru_RU |
dc.type | Thesis | ru_RU |
Appears in Collections: | Наукові праці. Кафедра внутрішньої медицини № 3 та ендокринології |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
THE_INFLUENCE_OF_DAPAGLIFLOSIN_ON_THE_LEVEL_OF.438.pdf | 173,3 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.